Markets
Painted desert. Arizona. United States of America. North America
Painted desert in Arizona (Riccardo Lombardo/Getty Images)

Philip Morris already sold enough Zyn in 2025 to span Route 66

The company beat Wall Street estimates for the first three months of the year, driven largely by growth in its nicotine pouch business.

4/23/25 11:10AM

Tobacco giant Philip Morris International reported earnings on Wednesday that beat Wall Street estimates, bolstered by the wild success of its Zyn nicotine pouches.

The company rose after it reported an earnings per share of $1.69, compared to the $1.61 analysts polled by FactSet were expecting. It also reported quarterly sales of $9.3 billion, more than the $9.1 billion the Street was penciling in, driven largely by the growth in Zyn.

Philip Morris sold 223.4 million cans of Zyn in the first three months of 2025, up more than 50% from the same period last year. Stacked side by side like a plastic tubular nicotine pipeline, that’s enough cans to span the length of US Route 66.

The company now expects to sell 800 million to 840 million cans in 2025, up from 780 million to 820 million. Philip Morris bought Swedish Match, the original maker of Zyn, in late 2022, and since then sales have exploded. Nicotine pouches are particularly popular with young people, who are increasingly moving away from cigarettes, and Zyn is the only nicotine pouch brand authorized by the Food and Drug Administration.

Philip Morris is up nearly 40% this year amid broader market turmoil fueled by tariff fears. Tobacco manufacturing, including Zyn, is predominantly domestic and therefore less affected by trade uncertainty.

More Markets

See all Markets
markets

Jeep maker Stellantis surges as CEO says the automaker is in productive tariff talks with the US

Shares of Jeep and Dodge maker Stellantis are up more than 8% in Thursday afternoon trading, following comments from the automaker’s new CEO, Antonio Filosa, at a European auto conference.

On tariffs, Filosa said that Stellantis has had a “very productive exchange of ideas” with the Trump administration on the company’s manufacturing footprint and that the environment around the levies is “getting clearer and clearer.”

The US is Stellantis’ top priority, according to Filosa, and the company has taken efforts to turn things around in the market, where its struggled with sales in recent years. To fuel the turnaround, Stellantis is bringing back its popular Jeep Cherokee, which it discontinued in 2023.

As of 12:45 p.m. ET, Stellantis’ trading volume was at more than 140% of its average over the past 30 days.

markets

Tempus AI jumps on FDA clearance of AI-enabled tool to analyze cardiac MRIs

Tempus AI, a midcap medical diagnostics company that’s highlighted a push to incorporate AI technology into its products, surged on Thursday after announcing the FDA had issued a “510(k) clearance” of a new AI-enabled tool to analyze cardiac imagery from MRIs.

A 510(k) clearance — used for devices that are considered relatively low risk — essentially allows a product to be sold in the US.

While the company has never turned a profit, even on an adjusted basis, its sales are growing rapidly and the stock has had a great year, rising more than 160% in 2025.

For more on the company, check out our interview with its CEO, Eric Lefkofsky.

While the company has never turned a profit, even on an adjusted basis, its sales are growing rapidly and the stock has had a great year, rising more than 160% in 2025.

For more on the company, check out our interview with its CEO, Eric Lefkofsky.

markets

Micron surges as Citi boosts price target to $175

Micron is on the move this morning, gapping higher and continuing to trade up double digits after Citi boosted its view on how much the shares can run.

Analyst Christopher Danely raised his price target on the memory chipmaking specialist to $175 from $150, while maintaining a “buy” rating. The average analyst price target of $151 has now been shattered by Micron’s rise today, and the stock is trading at its highest level since June 2024.

This continues Micron’s advance as OpenAI’s dogged determination to burn through cash to enhance its AI capabilities provides a broad lift to the space, punctuated by Oracle’s massive gain on Wednesday.

Call demand is running hot: just 13 minutes into the session, volumes are running at 106,157 compared to a 20-day average of 88,888.

Micron is slated to report quarterly results on September 23.

markets

Centene rises after affirming full-year guidance

Centene soared in early trading after affirming its full-year guidance ahead of the Deutsche Bank 2025 Healthcare Summit on Thursday.

The company reiterated its expectation for adjusted diluted earnings per share to be approximately $1.75. At the conference, Centene executives also said they expect a higher percentage of its Medicare enrollees to be on more lucrative, top-rated plans next year, according to Bloomberg.

Earlier this week, UnitedHealth also reiterated its guidance and said it expects to have more top-rated plans in the coming year. The government rates insurance companies offering Medicare Advantage plans, and higher-rated plans are eligible for bonuses that can significantly increase a plan’s revenue.

Insurance companies that sell government-sponsored plans took a dive earlier this year amid unexpected rising costs. The recent announcements from both Centene and UnitedHealth may be a sign that the worst is behind them.

markets

Delta boosts its third-quarter sales outlook on improved travel demand

Delta Air Lines reaffirmed its full-year earnings outlook on Thursday, seeing US travel demand hold strong for the rest of the year.

Citing “improved demand trends,” the airline also elevated its sales forecast for the third quarter to an increase of between 2% and 4%. In July, it guided for 0% to 4% growth.

The move marks a turnaround from just five months ago, when Delta and many of its rivals pulled their full-year earnings outlooks as growth stalled on “broad economic uncertainty.” At the beginning of the year, Delta said 2025 had the chance to be its best fiscal year in a century.

After plunging earlier this year, Delta’s shares are essentially flat in 2025.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.